Beurs.nl monitor iconMarkt Monitor
  • AEX +0,32 819,56 +0,04%
  • DE40 0,00 20.374,10 0,00%
  • US500^ 0,00 5.358,26 0,00%
  • US30^ 0,00 40.214,00 0,00%
  • EUR/USD 0,00 1,1335 -0,22%
  • WTI 0,00 61,48 0,00%
  • Gold spot -18,53 3.218,94 -0,57%

BioPharma Terug naar discussie overzicht

enteromedics leuk gokje?

9 Posts
| Omlaag ↓
  1. [verwijderd] 5 december 2016 23:37
    Een klein plukje aandeeltjes enteromedics en afwachten kan weinig kwaad natuurlijk. Daar raken we niet van in de goot, maar een beweging van een paar cent omhoog is al snel leuk lijkt mij.

    EnteroMedics Inc. (NASDAQ:ETRM) stock is presently standing at about $0.05 and lots of equity research firms seem to have a target price set on the stock. The median one-year price target of 2 analysts covering the company is $1.10, which suggests the stock could still rise over 95 percent. The highest analyst price target is $2.00, which implies a rally of -3800 percent. And a quick view of analyst notes show that 1 are rating the stock a buy while 0 rate ETRM a strong buy. There are 1 equity research firms advocating a Hold and 0 consider it Sell.

    ROTH Capital analysts provided their view on EnteroMedics Inc. (NASDAQ:ETRM) recently. The rating firm issued a Neutral rating to this company in a research note released on Jun 09, 2016. Northland Securities analysts disclosed their opinion on EnteroMedics Inc. (NASDAQ:ETRM) recently. The rating firm gave a Outperform rating to this stock in a research note published on Jun 29, 2012. According to a research note disclosed on Jan 09, 2009, analysts at Argus have lowered their rating on these shares from Hold to Sell.

    EnteroMedics Inc. (NASDAQ:ETRM) Transactions Roundup

    Several insiders were part of recent insider activity for the stock. Its SVP, Ops & Bus Dev DeLange Peter M. Purchased 20,000 company shares for $11000, in a transaction on 2016-06-03. Following the transaction, the SVP, Ops & Bus Dev is left with a stake of 11 shares, currently valued at $1. Meanwhile, CEO GLADNEY DAN W purchased 50,000 shares worth $135000, through a transaction dated 2015-11-12. Following the completion of the transaction, the insider is left with a stake of 50,000 shares, amounting $2500. ETRM Chrmn, Pres & CEO KNUDSON MARK B also purchased 20,667 shares, at a stock price of $2.4. This transaction occurred on 2015-11-12 totals $49000.6. After this transaction, the insider’s stake stands at 45,011 shares, with a market value of $2251.


    Executives hold 0.99 percent of the stock. Kevin G. Douglas is one of the biggest insider owners in EnteroMedics Inc. (NASDAQ:ETRM), according to U.S. Securities and Exchange Commission (SEC) filings. The insider owns 3,010,852 shares which have current market value of around $150542.6.Mr. Dan W. Gladney is another major inside shareholder in the company. The insider owns 134,745 shares as of 0.12%, currently worth $6737.25. Dr. Mark B. Knudson, PhD is ranked as third insider holder of the stock. This insider holds 40,867 shares with a market value around $2043.35 as of recent close.

    EnteroMedics Inc. (NASDAQ:ETRM) Earnings Outlook

    In EnteroMedics Inc. (NASDAQ:ETRM)’s latest quarter, EPS moved to $-0.17 from $-0.49 in preceding quarter and revenues reached at $0.30M compared to $0.28M. Analysts had expected EnteroMedics Inc. (NASDAQ:ETRM) to post net income of about $-0.50 per share on $0.34M in revenue. Looking ahead, analysts on average predict that earnings for the current quarter would come in in the range of $-0.50 to $-0.38. That is compared with the $-0.95 in EPS it reported during the same period a year ago.

    FacebookTwitterGoogle+PinterestLinke
  2. [verwijderd] 9 januari 2017 12:16
    Even van weg geweest, RS gehad 70:1 op een aardig lage koers en daarna verder weggezakt. Van 4,25 na RS tot onder de 2. vrijdag gekkenhuis geweest met dit aandeel. Begon donderdag al met meer dan 100% en vrijdag stond het aandeel ruim boven de 9.
    Ik heb te vroeg verkocht. Wel leuke winst genomen, maar schelde bijna 3 dollar per stukje .... haastige spoed .. voor kapitaal niet goed.
9 Posts
|Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beurs.nl

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.163
AB InBev 2 5.544
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 52.507
ABO-Group 1 25
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 267
Accsys Technologies 23 10.931
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 193
Adecco 1 1
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.892
Aedifica 3 927
Aegon 3.258 323.213
AFC Ajax 538 7.093
Affimed NV 2 6.306
ageas 5.844 109.909
Agfa-Gevaert 14 2.074
Ahold 3.538 74.363
Air France - KLM 1.025 35.331
AIRBUS 1 12
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.072
Alfen 16 25.503
Allfunds Group 4 1.525
Almunda Professionals (vh Novisource) 651 4.252
Alpha Pro Tech 1 17
Alphabet Inc. 1 427
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.826
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.837 244.271
AMG 972 134.761
AMS 3 73
Amsterdam Commodities 305 6.757
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 501
Antonov 22.632 153.605
Aperam 92 15.106
Apollo Alternative Assets 1 17
Apple 5 387
Arcadis 252 8.808
Arcelor Mittal 2.035 321.097
Archos 1 1
Arcona Property Fund 1 287
arGEN-X 17 10.380
Aroundtown SA 1 221
Arrowhead Research 5 9.759
Ascencio 1 30
ASIT biotech 2 697
ASMI 4.108 39.700
ASML 1.767 112.340
ASR Nederland 21 4.522
ATAI Life Sciences 1 7
Atenor Group 1 523
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 14.351
Axsome Therapeutics 1 177
Azelis Group 1 67
Azerion 7 3.463